logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (v) Distribution of new inpatient clients by age group for each primary drug

Substance<1515-1920-2425-2930-3435-3940-4445+Mean ageAge known (base)Age not known
Opiates5.542.730.611.54.72.61.11.321.8215482
Cocaine5.036.233.211.19.03.01.01.522.71998
Stimulants12.359.518.34.93.01.60.20.119.383042
Hypnotics and sedatives6.116.414.911.89.98.010.322.531.626231
Hallucinogens44.433.322.20.00.00.00.00.016.890
Volatile substances42.145.88.82.30.90.00.00.016.62164
Cannabis 32.850.112.12.71.40.30.50.117.587720
Other substances 42.617.611.35.95.92.54.99.322.32044
Total15.144.322.58.14.12.21.42.320.94751191

Notes:

 Countries reporting data: BG, CZ, DK, IE, EL, CY, RO, SK, FI, SE, TR 

 The number of treatment clients in each country is listed in [Table TDI-7]. 

 See also ''TDI-108-New inpatient age at first use and primary drug.xls'' on distribution by country and ''General notes for interpreting data'' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - Table TDI inpatient treatment centres. 

Page last updated: Monday, 12 November 2007